BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 7, 2024
Breaking News: Two copies of ApoE4 cause genetic form of Alzheimer’s
See today's BioWorld Science
Home
» Anwita Biosciences presents AWT-030, a bifunctional IL-21 fusion protein with enhanced safety, half-life and antitumor activity
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Immuno-oncology
Anwita Biosciences presents AWT-030, a bifunctional IL-21 fusion protein with enhanced safety, half-life and antitumor activity
April 25, 2023
No Comments
Researchers from Anwita Biosciences Inc. presented preclinical data for AWT-030, a first-in-class bifunctional IL-21 fusion protein being...
BioWorld Science
Conferences
Cancer
Immuno-oncology